Genetics

Nonprofit run by former CEO Anne Wojcicki wins bid to acquire 23andMe
Health

Nonprofit run by former CEO Anne Wojcicki wins bid to acquire 23andMe

By
June 16, 2025
Dozens of states sue to block the sale of 23andMe’s genetic data after its former CEO pushes the purchase price $50 million higher
Health

Dozens of states sue to block the sale of 23andMe’s genetic data after its former CEO pushes the purchase price $50 million higher

By
June 12, 2025
Katherine Stueland, president and CEO of GeneDx
Conferences

Jamie Dimon says AI will mean people live to 100: It’s possible, says genetic testing CEO, but relies on these three factors 

By
May 6, 2025
Katherine Stueland
Newsletters

At a family reunion she discovered multiple relatives had cystic fibrosis. Decades later she’s built a $2.6 billion genetic testing company

By Emma Hinchliffe and Nina Ajemian
April 8, 2025
Katherine Stueland
Tech

As a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company

By
March 31, 2025
23andMe users are being urged to delete their data. Here’s how to do it
Health

23andMe users are being urged to delete their data. Here’s how to do it

By Alexa Mikhail and Beth Greenfield
March 24, 2025
This company is launching a genetic matching feature for future parents—and the CEO says ‘it has nothing to do with eugenics’ 
Life

This company is launching a genetic matching feature for future parents—and the CEO says ‘it has nothing to do with eugenics’ 

By
March 23, 2025
A young woman undergoes a brain scan.
Aging Well

Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug

By
February 6, 2025
A spine-zapping implant helped 3 people with a muscle-wasting disease walk better
Health

A spine-zapping implant helped 3 people with a muscle-wasting disease walk better

By Lauran Neergaard and The Associated Press
February 5, 2025
An older man wearing a business suit holds a pill in one hand and a glass of water in the other.
Health

The aspirin mistake: 29 million take it daily, not realizing costs outweigh benefits

By
February 4, 2025
As part of its quest to “discover the science of humanity,” the Truveta Genome Project will gather the de-identified genetic data of tens of millions of consented volunteers, health data startup Truveta announced Jan. 13, 2025.
Health

Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers

By
January 16, 2025
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.
Health

Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows

By
December 20, 2024
Anne Wojcicki, wearing a red dress, sits in a white chair as she speaks.
Tech

After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health

By
November 12, 2024
office building with 23andMe sign on the front lawn
Newsletters

23andMe appoints three former CFOs as new directors—after the previous board all resigned

By
October 31, 2024
How to delete your DNA data from 23andMe
Health

How to delete your DNA data from 23andMe

By
October 5, 2024

Most Popular